Provectus announces publication of Moffitt Cancer Center research on PV-10

Provectus (PVCT) Biopharmaceuticals announced the publication of preclinical research by Christine Chung, MD and her team at Moffitt Cancer Center in Tampa, Florida, evaluating intratumoral PV-10 in models of head and neck squamous cell carcinoma, HNSCC. The study, published in Molecular Cancer Therapeutics, highlights novel mechanistic findings that could support future clinical development of PV-10 in locally recurrent HNSCC. The article, titled “PV-10 triggers immunogenic cell death in head and neck squamous cell carcinoma via endoplasmic reticulum stress and apoptosis.”